The first Ebola drug trial in Africa has started with three healthcare workers in Mali receiving an experimental vaccine. It comes as the World Health Organisation (WHO) today warned the virus is now 'entrenched' in the capital cities of the three worst-hit countries, and is accelerating in almost all settings. The trial started on October 8, with the first health worker receiving the drug, followed by two colleagues yesterday. Over the course of the trial 37 more healthcare workers will be given the vaccine. The first Ebola drug trial in Africa has started with three healthcare workers in Mali receiving an experimental vaccine. Scientists say if successful it will 'alter the dynamic of the outbreak'

A second trial on African soil is expected to begin soon in the Gambia, to run in parallel with the

OPTIONS:
- Africa study.
- African study.
- Bruce Aylward study.
- Ebola study.
- Gambia study.
- Guinea study.
- Liberia study.
- Mali study.
- Sierra Leone study.
- WHO study.
- World Health Organisation study.


Mali study.